Arrowhead Pharmaceuticals Stock Analysis

Arrowhead Stock Analysis Notes

About 80.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 482.39. Arrowhead Pharmaceuticals recorded a loss per share of 5.0. The entity last dividend was issued on the 29th of October 2010. The firm had 1:10 split on the 17th of November 2011. Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Arrowhead Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Pasadena, California. Arrowhead Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 329 people. For more info on Arrowhead Pharmaceuticals please contact Christopher Anzalone at 626 304 3400 or go to https://arrowheadpharma.com.

Arrowhead Pharmaceuticals Investment Alerts

Arrowhead Pharmaceuticals Upcoming and Recent Events

Arrowhead Largest EPS Surprises

View All Earnings Estimates

Arrowhead Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Arrowhead Stock Institutional Investors

Note, although Arrowhead Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arrowhead Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.53 B.

Arrowhead Profitablity

Management Efficiency

Arrowhead Pharmaceuticals has return on total asset (ROA) of (0.4072) % which means that it has lost $0.4072 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5184) %, meaning that it created substantial loss on money invested by shareholders. Arrowhead Pharmaceuticals' management efficiency ratios could be used to measure how well Arrowhead Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 01/31/2025, Return On Tangible Assets is likely to drop to -0.5. In addition to that, Return On Capital Employed is likely to drop to -0.7. At this time, Arrowhead Pharmaceuticals' Total Assets are relatively stable compared to the past year. As of 01/31/2025, Non Current Assets Total is likely to grow to about 536.5 M, while Net Tangible Assets are likely to drop slightly above 202.9 M.

Technical Drivers

As of the 31st of January, Arrowhead Pharmaceuticals shows the Risk Adjusted Performance of 0.0314, downside deviation of 4.27, and Mean Deviation of 2.92. Arrowhead Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Arrowhead Pharmaceuticals standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Arrowhead Pharmaceuticals is priced correctly, providing market reflects its regular price of 20.23 per share. Given that Arrowhead Pharmaceuticals has jensen alpha of 0.0178, we suggest you to validate Arrowhead Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.

Arrowhead Pharmaceuticals Price Movement Analysis

Arrowhead Pharmaceuticals Insider Trading Activities

Arrowhead Pharmaceuticals Outstanding Bonds

Arrowhead Pharmaceuticals Predictive Daily Indicators

Arrowhead Pharmaceuticals Corporate Filings

Arrowhead Pharmaceuticals Forecast Models

Arrowhead Pharmaceuticals' time-series forecasting models are one of many Arrowhead Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arrowhead Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arrowhead Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arrowhead shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arrowhead Pharmaceuticals. By using and applying Arrowhead Stock analysis, traders can create a robust methodology for identifying Arrowhead entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arrowhead analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Arrowhead analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Arrowhead Pharmaceuticals stock analysis indicators help investors evaluate how Arrowhead Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Arrowhead Pharmaceuticals shares will generate the highest return on investment. By understating and applying Arrowhead Pharmaceuticals stock analysis, traders can identify Arrowhead Pharmaceuticals position entry and exit signals to maximize returns.

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.